This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignees: Griffth University, La Trobe University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 22 
Years Active: 2017
Title: The Innovative Contributions of Moses Lee in Malaria Vaccine Development
Introduction
Moses Lee is a notable inventor based in Holland, MI (US), recognized for his significant contributions to the field of immunology. His work primarily focuses on developing a blood-stage malaria vaccine, which has the potential to impact global health positively. With a single patent to his name, Lee's innovative approach addresses a critical need in malaria treatment and prevention.
Latest Patents
Moses Lee holds a patent for an immunogenic composition designed for use as a blood-stage malaria vaccine. This patent outlines a method of producing the immunogenic composition and a treatment method for malaria. The composition includes isolated or purified merozoites or red blood cells infected with merozoites, treated with centanamycin or tafuramycin A. Notably, the immunogenic composition does not require an adjuvant, and a single dose is sufficient to protect an animal against subsequent malaria infections by the same isolate, strain, or species used in the composition, as well as by one or more heterologous isolates, strains, or species.
Career Highlights
Throughout his career, Moses Lee has worked with esteemed institutions, including La Trobe University and Griffith University. His research and innovations have contributed to advancing the understanding and treatment of malaria, a disease that affects millions worldwide. His dedication to scientific research and innovation has positioned him as a key figure in the fight against malaria.
Collaborations
Moses Lee has collaborated with notable colleagues, including Michael Francis Good and Terry W Spithill. These partnerships have further enhanced his research efforts and contributed to the development of effective malaria treatments.
Conclusion
Moses Lee's innovative work in developing a blood-stage malaria vaccine showcases his commitment to addressing global health challenges. His contributions to immunology and collaboration with esteemed institutions and colleagues highlight the importance of innovation in the fight against diseases like malaria.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile